Ulmedt
ActiveUlmedt has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €68k and a net result of €3k. Equity is growing by ~54.1% per year across the filed fiscal years. Its solvency ranks better than 78% of 11200 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).
Checked score
Score 2025
78
/ 100
Excellent▼ -7 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability20▼-39
Solvency100=
Growth52▼-26
Stability100
Bankruptcy probability, 12 months
0.5%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €5k at 30 days acceptable
Liquidity ample (current ratio 4.34 against 10.28 in 2024), and 23% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
77%
Return on assets
3%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-08-2026, 29 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
29 d late
2024
28 d late
2023
31 d late
2022
32 d early
2021
54 d late
2020
40 d early
2019
52 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
16-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€68k▲ 4.1%
2024 · €65k
2018: €-40k
2019: €-25k
2020: €-22k
2021: €-11k
2022: €15k
2023: €57k
2024: €65k
2018 → 2025
Total assets
€88k▲ 22.1%
2024 · €72k
2018: €53k
2019: €66k
2020: €71k
2021: €70k
2022: €71k
2023: €69k
2024: €72k
2018 → 2025
Net result
€3k▼ 65.4%
2024 · €8k
2018: €6k
2019: €15k
2020: €3k
2021: €11k
2022: €26k
2023: €43k
2024: €8k
2018 → 2025
Working capital
€68k▲ 4.1%
2024 · €65k
2018: €-40k
2019: €-24k
2020: €-22k
2021: €-11k
2022: €15k
2023: €57k
2024: €65k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€-11k-€15k€57k▲ 292%€65k▲ 13.4%€68k▲ 4.1%
Operating result€11k-€26k▲ 132%€43k▲ 66.5%€8k▼ 81.7%€3k▼ 66.7%
Net result€11k-€26k▲ 135%€43k▲ 66.9%€8k▼ 82.0%€3k▼ 65.4%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 67% below 2024 and is the lowest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €88k
Equity
€68k▲ 4.1%
Debt
€20k▲ 189%
The debt ratio rises from 9.7% to 23.0%: debt grows faster than equity.
Key figures and ratios
Solvency
77.0%▼
2024 · 90.3%
Current ratio
4.34▼
2024 · 10.28
Quick ratio
4.34▼
2024 · 8.76
Debt / equity
0.30▲
2024 · 0.11
ROE
3.9%▼
2024 · 11.8%
ROA
3.0%▼
2024 · 10.7%
Debt
€20k▲
2024 · €7k
Debt ≤ 1 year
€20k▲
2024 · €7k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€72k€88k▲
Current assets29/58€72k€88k▲
Stocks and contracts in progress3€11k-
Stocks30/36€11k-
Amounts receivable within one year40/41€40k€71k▲
Trade receivables40€23k€55k▲
Other amounts receivable41€17k€16k▼
Cash at bank and in hand54/58€19k€17k▼
Deferred charges and accrued income490/1€2k€77▼
Equity and liabilities
Total equity and liabilities10/49€72k€88k▲
Equity10/15€65k€68k▲
Contributions10/11€100k€100k=
Profit (loss) carried forward14€-35k€-32k▲
Amounts payable17/49€7k€20k▲
Amounts payable within one year42/48€7k€20k▲
Trade debts44€6k€18k▲
Suppliers440/4€6k€18k▲
Taxes, remuneration and social security45€620€2k▲
Taxes450/3€620€2k▲
Income statement
Code20242025
Other operating charges640/8€2k€2k▼
Gross operating margin9900€10k€4k▼
Operating profit (loss)9901€8k€3k▼
Financial income75/76B€27€96▲
Recurring financial income75€27€96▲
Financial charges65/66B€185€49▼
Recurring financial charges65€185€49▼
Profit (loss) for the period before taxes9903€8k€3k▼
Profit (loss) for the period9904€8k€3k▼
Profit (loss) for the period to be appropriated9905€8k€3k▼
Appropriation of the result
Profit (loss) to be appropriated9906€-35k€-32k▲
Profit (loss) brought forward from the previous period14P€-43k€-35k▲
The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
29-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 29 days late
2025
31-12
Financial
Weakest financial yearnet €3k ▼65.4%
Net result drops to €3k, the lowest in the series.
28-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 28 days late
2024
31-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 31 days late
2023
31-12
Financial
Highest result since 2018net €43k ▲66.9%
Operating result €43k, net result €43k, both a record.
31-12
Financial
Liquidity times 5current ratio 6.09
Current ratio from 1.26 to 6.09; short-term debt falls from €56k to €11k.
29-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
23-09
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 54 days late
2021
21-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
21-09
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 52 days late
2019
26-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 26 days late
2018
09-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
25-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 25 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Diepenbeek · 1 establishment unit since 2008
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Kastanjelaan 433590 DiepenbeekGround area
1,811 m²
Building footprint
173 m²
Parcel 71403G0071/00M000, Flanders. Linked by address, not a title deed.
1 establishment unit
Ulmedt
since 20082.169.090.145
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71403G0071/00M000 | Flanders | 1,810 m² | 1 · 173 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
MEDICOTRONIX
BE 0441.707.712
Fleurus · Eq €68k
BM 2 CONSULTING
BE 0742.799.571
Beersel · Eq €68k
IMTEC DIAGNOSTICS
BE 0449.365.069
Antwerpen · Eq €68k
The Hotel Company
BE 0747.583.849
Gent · Eq €66k
MEDIDAT
BE 0428.034.076
Antwerpen · Eq €66k
Of 1,893 companies in sector 46460 we hold annual accounts for 1,113. 534 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded15-02-2008
Fiscal year end31-12
Activities, NACEBEL
46460Wholesale of pharmaceutical and medical goods
70200Business and other management consultancy
70220Business consulting
77225Rental and leasing activities
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
2 entriesE-mail:info@ulmedt.com
Phone:011871540